High-performance invasive brain-computer interface nears clinical validation stage
According to Li, by working with Peking University First Hospital, Xuanwu Hospital Capital Medical University and Beijing Tiantan Hospital of the Capital Medical University, Neucyber Neurotech has finished five Beinao-1 implantation operations since the beginning of 2025, delivering motor and speech rehabilitation and functional substitution for individuals with spinal cord injuries, stroke, or amyotrophic lateral sclerosis.
Beinao-1 is the world's first high-throughput wireless fully implanted BCI system and is an electroencephalogram-based BCI system.
"Next, we will complete the official registered clinical trial for the Beinao-1 intelligent BCI system, continuing to advance technological optimization and application expansion, bringing hope to more patients," Li added.
- Trade union body, judicial authorities highlight cases to safeguard workers' rights
- Beijing IP court's move to appoint technicians as investigators pays off
- Yearender: Diversity, integration drive Macao's new chapter in 2025
- Chinese team develops antiviral strategy that could change flu treatment
- UN body partners with private sector to set up sustainable patrol at nature reserve
- Nantong-Ningbo high-speed railway reaches a new milestone
